The use of systemic and topical fluoroquinolones

Committee on Infectious Diseases

Research output: Contribution to journalArticle

28 Scopus citations

Abstract

Appropriate prescribing practices for fluoroquinolones, as well as all antimicrobial agents, are essential as evolving resistance patterns are considered, additional treatment indications are identified, and the toxicity profile of fluoroquinolones in children has become better defined. Earlier recommendations for systemic therapy remain; expanded uses of fluoroquinolones for the treatment of certain infections are outlined in this report. Prescribing clinicians should be aware of specific adverse reactions associated with fluoroquinolones, and their use in children should continue to be limited to the treatment of infections for which no safe and effective alternative exists or in situations in which oral fluoroquinolone treatment represents a reasonable alternative to parenteral antimicrobial therapy.

Original languageEnglish (US)
Article numbere20162706
JournalPediatrics
Volume138
Issue number5
DOIs
StatePublished - Nov 2016

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'The use of systemic and topical fluoroquinolones'. Together they form a unique fingerprint.

  • Cite this

    Committee on Infectious Diseases (2016). The use of systemic and topical fluoroquinolones. Pediatrics, 138(5), [e20162706]. https://doi.org/10.1542/peds.2016-2706